Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISMatic: Psilocybin Efficacy With or Without Pimavanserin Pretreatment
NCT07610135Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin, pimavanserin, sponsored by Johns Hopkins University. Started Oct 2026; status: recruiting.
02
Drugs
psilocybinpimavanserin
Beyond the preview
Go deeper on NCT07610135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07610135.